| 1 |
35216831 | Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. | 2022 May |
2 |
| 2 |
33342073 | After cyclophosphamide exposure, granulosa cells recover their anti-müllerian hormone-producing ability but not their numbers. | 2021 Aug |
7 |
| 3 |
34519276 | Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment. | 2021 Oct 11 |
1 |
| 4 |
32799907 | Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study. | 2020 Aug 14 |
1 |
| 5 |
30113879 | AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. | 2019 Jan |
1 |
| 6 |
30669758 | [Effect of cyclophosphamide on ovarian function in patients with systemic lupus erythematosus in childbearing age]. | 2019 Jan 15 |
1 |
| 7 |
29270058 | Ovarian function after chemotherapy in young breast cancer survivors. | 2017 Dec |
1 |
| 8 |
24815955 | Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus. | 2015 Mar-Apr |
1 |
| 9 |
24878927 | Diminished ovarian reserve in Behçet's disease patients. | 2015 Jan |
1 |
| 10 |
25796551 | Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma? | 2015 May |
2 |
| 11 |
26667243 | Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide. | 2015 Dec 14 |
1 |
| 12 |
24881927 | Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? | 2014 |
1 |
| 13 |
23044647 | Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus. | 2013 Jan |
3 |
| 14 |
23833039 | Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. | 2013 Sep |
2 |